The AHR Regulates Cell Adhesion and Migration by Interacting with Oncogene and Growth Factor-Dependent Signaling

The AH Receptor in Biology and Toxicology

Volumn , Issue , 2011, Pages 485-497

  Roman, Angel Carlos ^a   Carvajal Gonzalez, Jose M ^a   Mulero Navarro, Sonia ^a   Gomez Duran, Aurea ^a   Rico Leo, Eva M ^a   Merino, Jaime M ^a   Fernandez Salguero, Pedro M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

AHR function, pathway interaction; AHR in cell adhesion, migration; Oncogene, growth factor dependent

Indexed keywords

EID: 84886001975     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118140574.ch33     Document Type: Chapter

References (117)

1. Massari, M. E. and Murre, C. (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Molecular and Cellular Biology, 20, 429-440.
2. Furness, S. G., Lees, M. J., and Whitelaw, M. L. (2007). The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH/PAS transcription factors. FEBS Letters, 581, 3616-3625.
3. Barouki, R., Coumoul, X., and Fernandez-Salguero, P. M. (2007). The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Letters, 581, 3608-3615.
4. Bock, K. W. and Kohle, C. (2006). Ah receptor: dioxinmediated toxic responses as hints to deregulated physiologic functions. Biochemical Pharmacology, 72, 393-404.
5. Puga, A., Tomlinson, C. R., and Xia, Y. (2005). Ah receptor signals cross-talk with multiple developmental pathways. Biochemical Pharmacology, 69, 199-207.
6. Nebert, D.W. and Dalton, T. P. (2006). The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nature Reviews Cancer, 6, 947-960.
7. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annual Review of Pharmacology and Toxicology, 35, 307-340.
8. Hankinson, O. (2005). Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Archives of Biochemistry and Biophysics, 433, 379-386.
9. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. Journal of Biological Chemistry, 279, 23847-23850.
10. Davarinos, N. A. and Pollenz, R. S. (1999). Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytoplasmic proteasome following nuclear export. Journal of Biological Chemistry, 274, 28708-28715.
11. Ma, Q. and Baldwin, K. T. (2000). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activation and DNA binding of AhR. Journal of Biological Chemistry, 275, 8432-8438.
12. Pollenz, R. S. (2002). The mechanism of AH receptor protein down-regulation (degradation) and its impact onAHreceptormediated gene regulation. Chemico-Biological Interactions, 141, 41-61.
13. Santiago-Josefat, B. and Fernandez-Salguero, P. M. (2003). Proteasome inhibition induces nuclear translocation of the dioxin receptor through an Sp1 and protein kinase C-dependent pathway. Journal of Molecular Biology, 333, 249-260.
14. Santiago-Josefat, B., Pozo-Guisado, E., Mulero-Navarro, S., and Fernandez-Salguero, P. M. (2001). Proteasome inhibition induces nuclear translocation and transcriptional activation of the dioxin receptor in mouse embryo primary fibroblasts in the absence of xenobiotics. Molecular and Cellular Biology, 21, 1700-1709.
15. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D.W., Rudikoff, S.,Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science, 268, 722-726.
16. Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S.,Ward, J. M., and Gonzalez, F. J. (1996). Aryl-hydrocarbon receptordeficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-pdioxin-induced toxicity. Toxicology and Applied Pharmacology, 140, 173-179.
17. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. (2000). Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proceedings of the National Academy of Sciences of the United States of America, 97, 779-782.
18. Hahn, M. E. (1998). The aryl hydrocarbon receptor: a comparative perspective. Comparative Biochemistry and Physiology, Part C, 121, 23-53.
19. Hahn, M. E. (2002). Aryl hydrocarbon receptors: diversity and evolution. Chemico-Biological Interactions, 141, 131-160.
20. Crews, S. T. and Brenman, J. E. (2006). Spineless provides a little backbone for dendritic morphogenesis. Genes & Development, 20, 2773-2778.
21. Corchero, J., Martin-Partido, G., Dallas, S. L., and Fernandez-Salguero, P. M. (2004). Liver portal fibrosis in dioxin receptornull mice that overexpress the latent transforming growth factor-beta-binding protein-1. International Journal of Experimental Pathology, 85, 295-302.
22. Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., and Bradfield, C. A. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 10442-10447.
23. Hogaboam, J. P., Moore, A. J., and Lawrence, B. P. (2008). The aryl hydrocarbon receptor affects distinct tissue compartments during ontogeny of the immune system. Toxicological Sciences, 102, 160-170.
24. Laiosa, M. D., Wyman, A., Murante, F. G., Fiore, N. C., Staples, J. E., Gasiewicz, T. A., and Silverstone, A. E. (2003). Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor. Journal of Immunology, 171, 4582-4591.
25. Fernandez-Salguero, P. M., Ward, J. M., Sundberg, J. P., and Gonzalez, F. J. (1997). Lesions of aryl-hydrocarbon receptordeficient mice. Veterinary Pathology, 34, 605-614.
26. Lund, A. K., Goens, M. B., Nunez, B. A., and Walker, M. K. (2006). Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice. Toxicology and Applied Pharmacology, 212, 127-135.
27. Vasquez, A., Atallah-Yunes, N., Smith, F. C., You, X., Chase, S. E., Silverstone, A. E., andVikstrom, K. L. (2003).Arole for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovascular Toxicology, 3, 153-163.
28. Benedict, J. C., Lin, T. M., Loeffler, I. K., Peterson, R. E., and Flaws, J. A. (2000). Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicological Sciences, 56, 382-388.
29. Tijet, N., Boutros, P. C., Moffat, I. D., Okey, A. B., Tuomisto, J., and Pohjanvirta, R. (2006). Aryl hydrocarbon receptorregulates distinct dioxin-dependent and dioxin-independent gene batteries. Molecular Pharmacology, 69, 140-153.
30. Sartor, M. A., Schnekenburger, M., Marlowe, J. L., Reichard, J. F.,Wang, Y., Fan, Y., Ma, C., Karyala, S., Halbleib, D., Liu, X., Medvedovic, M., and Puga, A. (2009). Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an extensive array of gene clusters that control morphogenetic and developmental programs. Environmental Health Perspectives, 117, 1139-1146.
31. Frericks, M., Burgoon, L. D., Zacharewski, T. R., and Esser,C. (2008). Promoter analysis of TCDD-inducible genes in a thymic epithelial cell line indicates the potential for cellspecific transcription factor crosstalk in the AhR response. Toxicology and Applied Pharmacology, 232, 268-279.
32. Puga, A., Ma, C., and Marlowe, J. L. (2009). The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochemical Pharmacology, 77, 713-722.
33. Elferink, C. J. (2003). Aryl hydrocarbon receptor-mediated cell cycle control. Progress in Cell Cycle Research, 5, 261-267.
34. Marlowe, J. L. and Puga, A. (2005). Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. Journal of Cellular Biochemistry, 96, 1174-1184.
35. Haarmann-Stemmann, T., Bothe, H., and Abel, J. (2009). Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochemical Pharmacology, 77, 508-520.
36. Gomez-Duran, A., Carvajal-Gonzalez, J. M., Mulero-Navarro, S., Santiago-Josefat, B., Puga, A., and Fernandez-Salguero, P. M. (2009). Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling. Biochemical Pharmacology, 77, 700-712.
37. Kung, T., Murphy, K. A., and White, L. A. (2009). The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochemical Pharmacology, 77, 536-546.
38. Mitra, S. K., Hanson, D. A., and Schlaepfer, D. D. (2005). Focal adhesion kinase: in command and control of cell motility. Nature Reviews Molecular Cell Biology, 6, 56-68.
39. Lee, J. M., Dedhar, S., Kalluri, R., and Thompson, E. W. (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. Journal of Cell Biology, 172, 973-981.
40. Li, S., Guan, J. L., and Chien, S. (2005). Biochemistry and biomechanics of cell motility. Annual Review of Biomedical Engineering, 7, 105-150.
41. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-890.
42. Sadek, C. M. and Allen-Hoffmann, B. L. (1994). Cytochrome P450IA1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. Journal of Biological Chemistry, 269, 16067-16074.
43. Sadek, C. M. and Allen-Hoffmann, B. L. (1994). Suspensionmediated induction of Hepa 1c1c7 Cyp1a-1 expression is dependent on the Ah receptor signal transduction pathway. Journal of Biological Chemistry, 269, 31505-31509.
44. Cho, Y. C., Zheng,W., and Jefcoate, C. R. (2004). Disruption of cell-cell contact maximally but transiently activates AhRmediated transcription in 10T1/2 fibroblasts. Toxicology and Applied Pharmacology, 199, 220-238.
45. Ikuta, T., Kobayashi, Y., and Kawajiri, K. (2004). Cell density regulates intracellular localization of aryl hydrocarbon receptor. Journal of Biological Chemistry, 279, 19209-19216.
46. Niermann, T., Schmutz, S., Erne, P., and Resink, T. (2003). Aryl hydrocarbon receptor ligands repress T-cadherin expression in vascular smooth muscle cells. Biochemical and Biophysical Research Communications, 300, 943-949.
47. Larsen, M. C., Brake, P. B., Pollenz, R. S., and Jefcoate, C. R. (2004). Linked expression of Ah receptor, ARNT, CYP1A1, and CYP1B1 in rat mammary epithelia, in vitro, is each substantially elevated by specific extracellular matrix interactions that precede branching morphogenesis. Toxicological Sciences, 82, 46-61.
48. Andreasen, E. A., Mathew, L. K., Lohr, C. V., Hasson, R., and Tanguay, R. L. (2007). Aryl hydrocarbon receptor activation impairs extracellular matrix remodeling during zebra fish fin regeneration. Toxicological Sciences, 95, 215-226.
49. Zodrow, J. M. and Tanguay, R. L. (2003). 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits zebrafish caudal fin regeneration. Toxicological Sciences, 76, 151-161.
50. Gomez-Duran, A., Mulero-Navarro, S., Chang, X., and Fernandez-Salguero, P. M. (2006). LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: role of extracellular proteases plasmin and elastase. Journal of Cellular Biochemistry, 97, 380-392.
51. Santiago-Josefat, B., Mulero-Navarro, S., Dallas, S. L., and Fernandez-Salguero, P. M. (2004). Overexpression of latent transforming growth factor-b binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts. Journal of Cell Science, 117, 849-859.
52. Kohle, C., Hassepass, I., Bock-Hennig, B. S.,Walter Bock, K., Poellinger, L., and McGuire, J. (2002). Conditional expression of a constitutively active aryl hydrocarbon receptor in MCF-7 human breast cancer cells. Archives of Biochemistry and Biophysics, 402, 172-179.
53. Wang, F., Samudio, I., and Safe, S. (2001). Transcriptional activation of cathepsin D gene expression by 17b-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Molecular and Cellular Endocrinology, 172, 91-103.
54. Peterson, T. C., Hodgson, P., Fernandez-Salguero, P., Neumeister, M., andGonzalez, F. J. (2000). Hepatic fibrosis and cytochrome P450: experimental models of fibrosis compared to AHR knockout mice. Hepatology Research, 17, 112-125.
55. Lahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., and Bradfield, C. A. (2005). The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Molecular Pharmacology, 67, 714-720.
56. Hushka, L. J., Williams, J. S., and Greenlee, W. F. (1998). Characterization of 2,3,7,8-tetrachlorodibenzofuran-dependent suppression and AH receptor pathway gene expression in the developing mouse mammary gland. Toxicology and Applied Pharmacology, 152, 200-210.
57. Carvajal-Gonzalez, J. M., Mulero-Navarro, S., Roman, A. C., Sauzeau, V., Merino, J. M., Bustelo, X. R., and Fernandez-Salguero, P. M. (2009). The dioxin receptor regulates the constitutive expression of the vav3 proto-oncogene and modulates cell shape and adhesion. Molecular Biology of the Cell, 20, 1715-1727.
58. Mulero-Navarro, S., Pozo-Guisado, E., Perez-Mancera, P. A., Alvarez-Barrientos, A., Catalina-Fernandez, I., Hernandez-Nieto, E., Saenz-Santamaria, J., Martinez, N., Rojas, J. M., Sanchez-Garcia, I., and Fernandez-Salguero, P. M. (2005). Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model. Journal of Biological Chemistry, 280, 28731-28741.
59. Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., and Yamamoto, T. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature, 377, 539-544.
60. Bustelo, X. R., Sauzeau,V., and Berenjeno, I. M. (2007). GTPbinding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays, 29, 356-370.
61. Fukata, M., Nakagawa, M., and Kaibuchi, K. (2003). Roles of Rho-family GTPases in cell polarisation and directional migration. Current Opinion in Cell Biology, 15, 590-597.
62. Hornstein, I., Alcover, A., and Katzav, S. (2004).Vav proteins, masters of the world of cytoskeleton organization. Cellular Signalling, 16, 1-11.
63. Movilla, N. and Bustelo, X. R. (1999). Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Molecular and Cellular Biology, 19, 7870-7885.
64. Couceiro, J. R., Martin-Bermudo, M. D., and Bustelo, X. R. (2005). Phylogenetic conservation of the regulatory and functional properties of the Vav oncoprotein family. Experimental Cell Research, 308, 364-380.
65. Fernandez-Salguero, P. M. (2010). A remarkable new target gene for the dioxin receptor: the Vav3 proto-oncogene links AhRto adhesion and migration. Cell Adhesion&Migration, 4, 172-175.
66. Barnes-Ellerbe, S., Knudsen, K. E., and Puga, A. (2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Molecular Pharmacology, 66, 502-511.
67. Kolluri, S. K.,Weiss, C., Koff, A., and Gottlicher, M. (1999). p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes & Development, 13, 1742-1753.
68. Hoffer, A., Chang, C. Y., and Puga, A. (1996). Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and-independent pathways. Toxicology and Applied Pharmacology, 141, 238-247.
69. Yang, X., Liu, D., Murray, T. J., Mitchell, G. C., Hesterman, E. V., Karchner, S. I., Merson, R. R., Hahn, M. E., and Sherr, D. H. (2005). The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells. Oncogene, 24, 7869-7881.
70. Marlowe, J. L., Knudsen, E. S., Schwemberger, S., and Puga, A. (2004). The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. Journal of Biological Chemistry, 279, 29013-29022.
71. Sasaki, A. T., Chun, C., Takeda, K., and Firtel, R. A. (2004). Localized Ras signaling at the leading edge regulates PI3K, cell polarity, and directional cell movement. Journal of Cell Biology, 167, 505-518.
72. Meng, D., Lv, D. D., Zhuang, X., Sun, H., Fan, L., Shi, X. L., and Fang, J. (2009). Benzo[a]pyrene induces expression of matrix metalloproteinases and cell migration and invasion of vascular smooth muscle cells. Toxicology Letters, 184, 44-49.
73. Diry, M., Tomkiewicz, C., Koehle, C., Coumoul, X., Bock, K. W., Barouki, R., and Transy, C. (2006). Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene, 25, 5570-5574.
74. Barouki, R. and Coumoul, X. (2009). Cell migration and metastasis markers as targets of environmental pollutants and the aryl hydrocarbon receptor. Cell Adhesion & Migration, 4, 72-76.
75. Bui, L. C., Tomkiewicz, C., Chevallier, A., Pierre, S., Bats, A. S., Mota, S., Raingeaud, J., Pierre, J., Diry, M., Transy, C., Garlatti, M., Barouki, R., and Coumoul, X. (2009). Nedd9/ Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene, 28, 3642-3651.
76. Seifert, A., Rau, S., Kullertz, G., Fischer, B., and Santos, A. N. (2009). TCDD induces cell migration via NFATc1/ATX-signaling in MCF-7 cells. Toxicology Letters, 184, 26-32.
77. Peng, T. L., Chen, J., Mao, W., Song, X., and Chen, M. H. (2009). Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biology, 10, 27.
78. Tauchi, M., Hida, A., Negishi, T., Katsuoka, F., Noda, S., Mimura, J., Hosoya, T., Yanaka, A., Aburatani, H., Fujii-Kuriyama, Y., Motohashi, H., and Yamamoto, M. (2005). Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Molecular and Cellular Biology, 25, 9360-9368.
79. Carvajal-Gonzalez, J. M., Roman, A. C., Cerezo-Guisado, M. I., Rico-Leo, E. M., Martin-Partido, G., and Fernandez-Salguero, P. M. (2009). Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGFbeta. Journal of Cell Science, 122, 1823-1833.
80. Ikuta, T., Namiki, T., Fujii-Kuriyama, Y., and Kawajiri, K. (2009). AhR protein trafficking and function in the skin. Biochemical Pharmacology, 77, 588-596.
81. Reynolds, L. E., Conti, F. J., Lucas, M., Grose, R., Robinson, S., Stone, M., Saunders, G., Dickson, C., Hynes, R. O., Lacy-Hulbert, A., and Hodivala-Dilke, K. (2005). Accelerated reepithelialization in beta3-integrin-deficient mice is associated with enhanced TGF-beta1 signaling. Nature Medicine, 11, 167-174.
82. Walisser, J. A., Bunger,M. K., Glover, E., and Bradfield, C. A. (2004). Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proceedings of the National Academy of Sciences of the United States of America, 101, 16677-16682.
83. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., and Simon, M. C. (1997). Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature, 386, 403-407.
84. Chang, C. C., Tsai, S.Y., Lin, H., Li, H. F., Lee,Y. H., Chou,Y., Jen, C. Y., and Juan, S. H. (2009). Aryl-hydrocarbon receptordependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene. Cellular and Molecular Life Sciences, 66, 3193-3205.
85. Juan, S. H., Lee, J. L., Ho, P. Y., Lee, Y. H., and Lee, W. S. (2006). Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells. European Journal of Pharmacology, 530, 1-8.
86. Ichihara, S., Yamada, Y., Ichihara, G., Nakajima, T., Li, P., Kondo, T., Gonzalez, F. J., and Murohara, T. (2007). A role for the aryl hydrocarbon receptor in regulation of ischemiainduced angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1297-1304.
87. Ichihara, S., Yamada, Y., Gonzalez, F. J., Nakajima, T., Murohara, T., and Ichihara, G. (2009). Inhibition of ischemia-induced angiogenesis by benzo[a]pyrene in a manner dependent on the aryl hydrocarbon receptor. Biochemical and Biophysical Research Communications, 381, 44-49.
88. Roman, A. C., Carvajal-Gonzalez, J. M., Rico-Leo, E. M., and Fernandez-Salguero, P. M. (2009). Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma. Journal of Biological Chemistry, 284, 25135-25148.
89. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M.,Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439.
90. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-442.
91. Lu, P. and Werb, Z. (2008). Patterning mechanisms of branched organs. Science, 322, 1506-1509.
92. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., and Shima, D. T. (2002). Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes & Development, 16, 2684-2698.
93. Guo, J., Sartor, M., Karyala, S., Medvedovic, M., Kann, S., Puga, A., Ryan, P., and Tomlinson, C. R. (2004). Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice. Toxicology and Applied Pharmacology, 194, 79-89.
94. Esser, C., Temchura, V., Majora, M., Hundeiker, C., Schwarzler, C., and Gunthert, U. (2004). Signaling via the AHR leads to enhanced usage of CD44v10 by murine fetal thymic emigrants: possible role for CD44 in emigration. International Immunopharmacology, 4, 805-818.
95. Temchura, V. V., Frericks, M., Nacken, W., and Esser, C. (2005). Role of the aryl hydrocarbon receptor in thymocyte emigration in vivo. European Journal of Immunology, 35, 2738-2747.
96. Qin, H. and Powell-Coffman, J. A. (2004). The Caenorhabditis elegans aryl hydrocarbon receptor, AHR-1, regulates neuronal development. Developmental Biology, 270, 64-75.
97. Qin, H., Zhai, Z., and Powell-Coffman, J. A. (2006). The Caenorhabditis elegans AHR-1 transcription complex controls expression of soluble guanylate cyclase genes in theURX neurons and regulates aggregation behavior. Developmental Biology, 298, 606-615.
98. Murray, J. C. (2002). Gene/environment causes of cleft lip and/or palate. Clinical Genetics, 61, 248-256.
99. Murray, J. C. and Schutte, B. C. (2004). Cleft palate: players, pathways, and pursuits. Journal of Clinical Investigation, 113, 1676-1678.
100. Mimura, J.,Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., and Fujii-Kuriyama, Y. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells, 2, 645-654.
101. Jezewski, P. A., Vieira, A. R., Nishimura, C., Ludwig, B., Johnson, M., O'Brien, S. E., Daack-Hirsch, S., Schultz, R. E., Weber, A., Nepomucena, B., Romitti, P. A., Christensen, K., Orioli, I. M., Castilla, E. E., Machida, J., Natsume, N., and Murray, J. C. (2003). Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. Journal of Medical Genetics, 40, 399-407.
102. Peters, J. M., Narotsky, M. G., Elizondo, G., Fernandez-Salguero, P. M., Gonzalez, F. J., and Abbott, B. D. (1999). Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicological Sciences, 47, 86-92.
103. Kaartinen, V., Voncken, J. W., Shuler, C., Warburton, D., Bu, D., Heisterkamp, N., and Groffen, J. (1995). Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nature Genetics, 11, 415-421.
104. Proetzel, G., Pawlowski, S. A.,Wiles,M. V., Yin,M., Boivin, G. P., Howles,P.N., Ding, J., Ferguson,M.W., andDoetschman, T.(1995). Transforming growth factor-beta 3 is required for secondary palate fusion. Nature Genetics, 11, 409-414.
105. Rice, R., Spencer-Dene, B., Connor, E. C., Gritli-Linde, A., McMahon, A. P., Dickson, C., Thesleff, I., and Rice, D. P. (2004). Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. Journal of Clinical Investigation, 113, 1692-1700.
106. Martinez-Alvarez, C., Blanco, M. J., Perez, R., Rabadan, M. A., Aparicio, M., Resel, E., Martinez, T., and Nieto, M. A. (2004). Snail family members and cell survival in physiological and pathological cleft palates. Developmental Biology, 265, 207-218.
107. Dietrich, C. and Kaina, B. (2010). The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis, 31, 1319-1328.
108. Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L., and Schwarz, M. (2004). A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Research, 64, 4707-4710.
109. Andersson, P., Rubio, C., Poellinger, L., and Hanberg, A. (2005). Gastric hamartomatous tumours in a transgenic mouse model expressing an activated dioxin/Ah receptor. Anticancer Research, 25, 903-911.
110. Peng, T. L., Chen, J., Mao, W., Liu, X., Tao, Y., Chen, L. Z., and Chen, M. H. (2009). Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer. World Journal of Gastroenterology, 15, 1719-1729.
111. Roth, M. J., Wei, W. Q., Baer, J., Abnet, C. C., Wang, G. Q., Sternberg, L. R., Warner, A. C., Johnson, L. L., Lu, N., Giffen, C. A., Dawsey, S. M., Qiao, Y. L., and Cherry, J. (2009). Aryl hydrocarbon receptor expression is associated with a family history of upper gastrointestinal tract cancer in a high-risk population exposed to aromatic hydrocarbons. Cancer Epidemiology, Biomarkers and Prevention, 18, 2391-2396.
112. Gluschnaider, U., Hidas, G., Cojocaru, G., Yutkin, V., Ben-Neriah,Y., and Pikarsky, E. (2010). b-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor. PLoS One, 5, e9060.
113. Chang, J. T., Chang, H., Chen, P. H., Lin, S. L., and Lin, P. (2007). Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clinical Cancer Research, 13, 38-45.
114. Ishida, M., Mikami, S., Kikuchi, E., Kosaka, T., Miyajima, A., Nakagawa, K., Mukai, M., Okada, Y., and Oya, M. (2010). Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. Carcinogenesis, 31, 287-295.
115. Koliopanos, A., Kleeff, J., Xiao,Y., Safe, S., Zimmermann, A., Buchler, M. W., and Friess, H. (2002). Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene, 21, 6059-6070.
116. Ikuta, T. and Kawajiri, K. (2006). Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor. Experimental Cell Research, 312, 3585-3594.
117. Roman, A. C., Benitez, D. A., Carvajal-Gonzalez, J. M., and Fernandez-Salguero, P. M. (2008). Genome-wide B1 retrotransposon binds the transcription factors dioxin receptor and Slug and regulates gene expression in vivo. Proceedings of the National Academy of Sciences of the United States of America, 105, 1632-1637.